Potential Benefits and Challenges of mRNA Cancer Vaccines

Abstract

Cancer is a complex and multifaceted disease that affects millions of people worldwide. One of the most promising advances in cancer treatment and prevention is the development of mRNA cancer vaccines. These vaccines are designed to harness the power of the immune system to target and eliminate cancer cells, offering a revolutionary approach to cancer therapy. Recently, one mRNA vaccine (mRNA-4157/v940) received FDA approval to be used as an adjuvant with Pembrolizumab therapy in melanoma patients. In addition, several mRNA cancer vaccines are in the development stage as follows.